View Older Stories View More Recent Stories

Dec 1, 2016 08:00AM LYRICA® (pregabalin) Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint
Dec 1, 2016 08:00AM IBM and Pfizer to Accelerate Immuno-oncology Research with Watson for Drug Discovery
Dec 1, 2016 08:00AM IBM and Pfizer to Accelerate Immuno-oncology Research with Watson for Drug Discovery
Nov 30, 2016 08:30AM Pfizer (PFE) Announces REFLECTIONS B3271002 Study Met Primary Endpoint
Nov 30, 2016 08:30AM Pfizer Announces Positive Top-Line Results from the Pivotal Comparative REFLECTIONS B3271002 Study for PF-05280014, a Potential Biosimilar to Herceptin®1 (trastuzumab)
Nov 29, 2016 08:21AM FDA Accepts BLA for Avelumab for Treatment of MCC for Priority Review (PFE)
Nov 29, 2016 08:17AM FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma for Priority Review
Nov 21, 2016 10:11AM Anthony J. Maddaluna, Executive Vice President and President of Pfizer Global Supply to Retire
Nov 16, 2016 05:10PM Pfizer (PFE) Announces Publication of Positive Phase 3 PALOMA-2 Data; Strong PFS Results Noted
Nov 16, 2016 05:09PM PALOMA-2 Phase 3 Study Published In The New England Journal Of Medicine Demonstrates Clinical Benefit Of Pfizer’s IBRANCE® (palbociclib) In First-Line ER+, HER2- Metastatic Breast Cancer
Nov 15, 2016 08:00AM Pfizer Announces Results from Phase 3 OPAL Clinical Development Program Investigating XELJANZ® (Tofacitinib Citrate) for Psoriatic Arthritis
Nov 14, 2016 02:00PM Eton Park Capital's 13F Shows New Stakes Twitter (TWTR), Kinder Morgan (KMI), Whitewave (WWAV), Increase in Microsoft (MSFT) (More...)
Nov 14, 2016 08:00AM Pfizer to Collaborate with National Cancer Institute to Study Three Immunotherapy Agents Targeting Multiple Cancers
Nov 14, 2016 06:45AM Pfizer (PFE) Announces Strong Data from PRECISION Trial in OA, RA Patients
Nov 13, 2016 04:57PM Landmark Study Demonstrates Pfizer’s Celebrex (Celecoxib)Has Similar Cardiovascular Risk As Compared To Prescription Doses Of Ibuprofen and Naproxen
Nov 11, 2016 06:02AM Pfizer (PFE) to Expand HAP; Includes Broader Access to Prevenar 13
Nov 11, 2016 06:00AM Pfizer Announces Major Expansion of Humanitarian Assistance Program
Nov 10, 2016 07:59AM Bristol-Myers Squibb and Pfizer to Deliver 12 New Eliquis® (apixaban) Presentations at American Heart Association (AHA) Scientific Sessions 2016
Nov 10, 2016 07:50AM Pfizer's (PFE) IBRANCE Receives European Approval as HR+/HER2- Metastatic Breast Cancer Treatment
Nov 10, 2016 02:00AM IBRANCE® (palbociclib) Receives Approval in European Union for the Treatment of Women with HR+/HER2- Metastatic Breast Cancer
Nov 7, 2016 06:47AM Pfizer (PFE) Announces Presentation of Additional XELJANZ Data at 2016 ACR/ARHP Annual Meeting
Nov 7, 2016 06:45AM Pfizer to Present Additional Research For XELJANZ® (Tofacitinib Citrate) In Rheumatologic Diseases, Including Rheumatoid Arthritis and Psoriatic Arthritis
Nov 3, 2016 09:06AM Spark Therapeutics (ONCE), Pfizer (PFE) Announce Presentation of Updated SPK-9001 Phase 1/2 data in Hemophilia B
Nov 3, 2016 09:05AM Spark Therapeutics and Pfizer Announce Updated Data from Hemophilia B Phase 1/2 Trial Suggesting Sustained Therapeutic Levels of Factor IX Activity
Nov 2, 2016 06:47AM Pfizer (PFE) Receives CFDA Approval of Prevenar 13 for Invasive Diseases
Nov 2, 2016 06:45AM Pfizer’s Prevenar 13® Receives Approval For Use in Infants and Children in China
Nov 1, 2016 06:31AM Pfizer (PFE) to Discontinue Bococizumab Development Program; Sees EPS Impact
Nov 1, 2016 06:30AM Pfizer Discontinues Global Development of Bococizumab, Its Investigational PCSK9 Inhibitor
Oct 31, 2016 03:00AM European Medicines Agency Validates the Marketing Authorization Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
Oct 20, 2016 08:00AM Debiopharm International SA Announces Clinical Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer in Cancer Immunotherapy
Oct 19, 2016 06:02PM CDC Advisory Committee on Immunization Practices Votes to Recommend New Dosing Schedule for Vaccination with TRUMENBA® (Meningococcal Group B Vaccine)
Oct 19, 2016 08:03AM Pfizer (PFE) Receives Award to Conduct GBS Vaccine Phase 1/2
Oct 19, 2016 08:00AM Pfizer Awarded Grant to Evaluate Vaccine to Protect Newborns Against Group B Streptococcus Infection
Oct 19, 2016 08:00AM Pfizer Awarded Grant to Evaluate Vaccine to Protect Newborns Against Group B Streptococcus Infection
Oct 17, 2016 04:06PM Pfizer (PFE) Says INFLECTRA Biosimilar Now Available in U.S.
Oct 17, 2016 04:05PM Pfizer Announces The U.S. Availability Of Biosimilar INFLECTRA® (infliximab-dyyb)
Oct 15, 2016 10:30AM Pfizer to Present New Data on XELJANZ® (Tofacitinib Citrate) for Ulcerative Colitis at UEG Week 2016
Oct 10, 2016 08:05AM Pfizer (PFE) Announces Strong Data from SUTENT Phase 3 in RCC; DFS Extension Noted
Oct 10, 2016 06:35AM Pfizer (PFE) Presents Encouraging New Data for INLYTA Combo Phase 1b in Adv. RCC
Oct 10, 2016 02:15AM First Positive Phase 3 Results in Adjuvant Setting for Renal Cell Carcinoma Show SUTENT® (sunitinib) Extended Disease Free Survival After Surgical Removal
Oct 9, 2016 10:30AM Pfizer Presents Promising New Immunotherapy Combination Data With INLYTA® (axitinib) In Advanced Renal Cell Carcinoma (RCC)
Oct 6, 2016 09:59AM Notable Mergers and Acquisitions 10/6: (ICUI)/(PFE) (KLAC)/(LRCX) (TWTR)/(GOOG) (WCG)
Oct 6, 2016 09:22AM Pre-Open Stock Movers 10/06: (ALQA) (SCYX) (ZUMZ) Higher; (ALNY) (TWTR) (MDCO) Lower (more...)
Oct 6, 2016 07:46AM ICU Medical (ICUI) to Acquire Pfizer's (PFE) Hospira Infusion Systems Business in $1B Deal
Oct 6, 2016 07:45AM ICU Medical Inc. to Acquire the Hospira Infusion Systems Business from Pfizer Inc. for $1 Billion in Cash and Stock
Sep 30, 2016 03:58PM Top 10 News for 9/26 - 9/30: Deutsche Bank Soars on Settlement; Twitter Back in the M&A Fray; Nike 'Just Didn't Do It' in Q1
Sep 28, 2016 08:51AM Pfizer (PFE) Closes Medivation (MDVN) Acquisition
Sep 28, 2016 08:50AM Pfizer Completes Acquisition of Medivation
Sep 28, 2016 06:00AM Pfizer to Showcase Progress of Broad-Based Oncology Portfolio at European Society for Medical Oncology (ESMO) 2016 Congress
Sep 23, 2016 08:32AM Pfizer (PFE) Says HSR Act Waiting Period in Medivation (MDVN) Acquisition has Expired
View More Recent Stories View Older Stories